Is Instil Bio Inc. (TIL) overvalued? · $51.3M cap
Instil Bio Inc. (TIL) is a biotechnology company listed on NASDAQ.
This page asks whether Instil Bio Inc. (TIL) looks expensive on cached numbers — not a short thesis.
No cached income statement for TIL, so there is no earnings base to call rich or cheap.
TIL currently screens at market cap $51.3M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next TIL 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the TIL stock page for the full model, not this heading.
Not investment advice.